Aileron Therapeutics, Inc. (ALRN)

NASDAQ: ALRN · IEX Real-Time Price · USD

4.785

-0.215 (-4.30%)

At close: Apr 19, 2024, 3:59 PM

4.439

-0.346 (-7.23%)

After-hours: Apr 19, 2024, 5:07 PM EDT

Aileron Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	80	14	11	51	42	16	12	155
Market Cap Growth	-	28.63%	-78.89%	20.49%	165.52%	28.63%	-92.01%	-
Enterprise Value	62	-3	-10	5	28	3	-3	104
PE Ratio	-0.88	-0.88	-0.39	-1.95	-2.00	-0.54	-0.39	-6.85
PB Ratio	11.48	2.01	0.58	1.16	3.48	0.99	0.63	3.25
P/FCF Ratio	-0.70	-0.70	-0.43	-2.14	-2.09	-0.60	-0.38	-7.50
P/OCF Ratio	-0.70	-0.70	-0.43	-2.15	-2.07	-0.60	-0.44	-7.56
EV/EBITDA Ratio	0.22	0.22	0.39	-0.20	-1.35	-0.09	0.10	-4.64
EV/EBIT Ratio	0.22	0.22	0.38	-0.20	-1.34	-0.09	0.09	-4.61
EV/FCF Ratio	0.17	0.17	0.42	-0.22	-1.40	-0.10	0.09	-5.05
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.03	0.31	0.27	-
Debt / EBITDA Ratio	0.00	0.00	0.00	-0.01	-0.02	-0.17	-0.17	-
Debt / FCF Ratio	0.00	0.00	0.00	-0.01	-0.02	-0.19	-0.17	-
Quick Ratio	3.95	3.95	6.28	10.19	3.64	3.13	3.86	10.39
Current Ratio	4.17	4.17	6.46	10.69	4.12	3.35	4.06	10.60
Return on Equity (ROE)	-139.40%	-139.40%	-103.10%	-49.50%	-165.80%	-143.80%	-105.60%	67.10%
Return on Assets (ROA)	-42.00%	-42.00%	-88.70%	-45.80%	-99.50%	-95.50%	-80.40%	-62.90%
Return on Capital (ROIC)	-234.69%	-234.69%	-148.19%	-60.38%	-163.33%	-142.11%	-127.90%	-48.14%
Earnings Yield	-19.89%	-113.64%	-253.93%	-51.32%	-50.00%	-184.30%	-254.64%	-14.60%
FCF Yield	-24.99%	-142.77%	-231.03%	-46.77%	-47.91%	-167.08%	-261.12%	-13.33%
Buyback Yield / Dilution	-1.31%	-1.31%	-2.23%	-154.70%	-42.11%	-66.48%	-98.01%	-1632.24%
Total Shareholder Return	-1.31%	-1.31%	-2.23%	-154.70%	-42.11%	-66.48%	-98.01%	-1632.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).